Fierce Pharma
Fierce Biotech
Fierce Healthcare
Fierce Life Sciences Events
Advertise
About Us
Biotech
Cell & Gene Therapy
Clinical Data
Oncology
Venture Capital
Deals
Research
Medtech
Devices
Diagnostics
AI and Machine Learning
CRO
Special Reports
Trending
Biologics
Clinical Development
Ophthalmology
Cell & Gene Therapy
Drug Development
Small Molecule Research & Development
Fierce 50
Special Report
Awards Gala
Awards
Outsourcing Awards
Innovation Awards
Resources
Fierce Events
Industry Events
Webinars
Podcasts
Whitepapers
Survey
Events
Subscribe
Subscribe
Biotech
Cell & Gene Therapy
Clinical Data
Oncology
Venture Capital
Deals
Research
Medtech
Devices
Diagnostics
AI and Machine Learning
CRO
Special Reports
Trending
Biologics
Clinical Development
Ophthalmology
Cell & Gene Therapy
Drug Development
Small Molecule Research & Development
Fierce 50
Special Report
Awards Gala
Awards
Outsourcing Awards
Innovation Awards
Resources
Fierce Events
Industry Events
Webinars
Podcasts
Whitepapers
Survey
Events
Subscribe
Fierce Pharma
Fierce Biotech
Fierce Healthcare
Fierce Life Sciences Events
Advertise
About Us
RNAi
Biotech
City lays foundation for RNAi renaissance with nearly $100M
In addition to a lead liver-directed candidate targeting clotting protein Factor XI, City aims to expand the reach of RNAi to the rest of the body.
Darren Incorvaia
Jun 8, 2026 4:00pm
Alnylam pays Inceptive $30M to transform siRNA design
Jun 4, 2026 4:13am
Irish biotech launches with $21M to shuttle RNAi meds to brain
Oct 1, 2025 10:34am
Arrowhead sues Ionis over patent dispute for Tryngolza rival
Sep 11, 2025 11:33am
Corsera launches with $50M for predictive AI tool, RNAi asset
Sep 2, 2025 6:30am
Biogen blueprints $1B CNS deal with RNAi biotech
May 27, 2025 10:55am
